COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, GA, USA; Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, GA, USA.
COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, GA, USA; Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Vaccine. 2022 Aug 5;40(33):4845-4855. doi: 10.1016/j.vaccine.2022.06.066. Epub 2022 Jul 4.
COVID-19 vaccination reduces SARS-CoV-2 infection and transmission. However, evidence is emerging on the degree of protection across variants and in high-transmission settings. To better understand the protection afforded by vaccination specifically in a high-transmission setting, we examined household transmission of SARS-CoV-2 during a period of high community incidence with predominant SARS-CoV-2 B.1.1.7 (Alpha) variant, among vaccinated and unvaccinated contacts.
We conducted a household transmission investigation in San Diego County, California, and Denver, Colorado, during January-April 2021. Households were enrolled if they had at least one person with documented SARS-CoV-2 infection. We collected nasopharyngeal swabs, blood, demographic information, and vaccination history from all consenting household members. We compared infection risks (IRs), RT-PCR cycle threshold values, SARS-CoV-2 culture results, and antibody statuses among vaccinated and unvaccinated household contacts.
We enrolled 493 individuals from 138 households. The SARS-CoV-2 variant was identified from 121/138 households (88%). The most common variants were Alpha (75/121, 62%) and Epsilon (19/121, 16%). There were no households with discordant lineages among household members. One fully vaccinated secondary case was symptomatic (13%); the other 5 were asymptomatic (87%). Among unvaccinated secondary cases, 105/108 (97%) were symptomatic. Among 127 households with a single primary case, the IR for household contacts was 45% (146/322; 95% Confidence Interval [CI] 40-51%). The observed IR was higher in unvaccinated (130/257, 49%, 95% CI 45-57%) than fully vaccinated contacts (6/26, 23%, 95% CI 11-42%). A lower proportion of households with a fully vaccinated primary case had secondary cases (1/5, 20%) than households with an unvaccinated primary case (66/108, 62%).
Although SARS-CoV-2 infections in vaccinated household contacts were reported in this high transmission setting, full vaccination protected against SARS-CoV-2 infection. These findings further support the protective effect of COVID-19 vaccination and highlight the need for ongoing vaccination among eligible persons.
COVID-19 疫苗接种可降低 SARS-CoV-2 感染和传播。然而,越来越多的证据表明,在不同变体和高传播环境下,疫苗的保护程度也不同。为了更好地了解疫苗接种在高传播环境下提供的具体保护作用,我们在社区发病率高且以 SARS-CoV-2 B.1.1.7(Alpha)变体为主的时期,对已接种疫苗和未接种疫苗的接触者中的家庭传播进行了研究。
我们在加利福尼亚州圣地亚哥县和科罗拉多州丹佛市进行了一项家庭传播调查,时间为 2021 年 1 月至 4 月。如果一个家庭中至少有一人有记录的 SARS-CoV-2 感染,就可以入组该家庭。我们从所有同意的家庭成员中收集了鼻咽拭子、血液、人口统计学信息和疫苗接种史。我们比较了已接种疫苗和未接种疫苗的家庭接触者之间的感染风险(IR)、实时聚合酶链反应(RT-PCR)循环阈值、SARS-CoV-2 培养结果和抗体状态。
我们从 138 个家庭中招募了 493 人。从 121/138 个家庭(88%)中鉴定出了 SARS-CoV-2 变体。最常见的变体是 Alpha(75/121,62%)和 Epsilon(19/121,16%)。家庭成员之间没有不同谱系的家庭。一名完全接种疫苗的二级病例为有症状(13%);其余 5 例为无症状(87%)。在 108 名未接种疫苗的二级病例中,105/108(97%)为有症状。在 127 个仅有一个原发性病例的家庭中,家庭接触者的感染率为 45%(146/322;95%置信区间[CI]40-51%)。未接种疫苗的接触者的观察到的感染率(130/257,49%,95%CI 45-57%)高于完全接种疫苗的接触者(6/26,23%,95%CI 11-42%)。完全接种疫苗的一级病例家庭中发生二级病例的比例(1/5,20%)低于未接种疫苗的一级病例家庭(66/108,62%)。
尽管在这个高传播环境中报告了已接种疫苗的家庭接触者中有 SARS-CoV-2 感染,但完全接种疫苗可预防 SARS-CoV-2 感染。这些发现进一步支持了 COVID-19 疫苗接种的保护作用,并强调了在符合条件的人群中持续接种疫苗的必要性。